EUVIMEDEUVIMED entdecken
Open Access · CC BY 2.0

DY131 activates ERRγ/TFAM axis to protect against metabolic disorders and acute kidney injury

Wei Gong iD, Lingling Lu, Haoyang Ma, Mingfeng Shan, Xinwen Fan, Mi Bai, Yue Zhang, Songming Huang, Zhanjun Jia iD, Aihua Zhang

Clinical Science · 2024

DOI: 10.1042/cs20240242 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Science, 2024. Verfasst von Wei Gong und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Children's Hospital of Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Acute Kidney Injury, Receptors, Estrogen. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 2.0). Gefördert von: Social Development Fund of Jiangsu Province, National Natural Science Foundation of China (NSFC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Renal tubular injury is considered as the main pathological feature of acute kidney injury (AKI), and mitochondrial dysfunction in renal tubular cells is implicated in the pathogenesis of AKI. The estrogen-related receptor γ (ERRγ) is a member of orphan nuclear receptors which plays a regulatory role in mitochondrial biosynthesis, energy metabolism and many metabolic pathways. Online datasets showed a dominant expression of ERRγ in renal tubules, but the role of ERRγ in AKI is still unknown. In the present study, we investigated the role of ERRγ in the pathogenesis of AKI and the therapeutic efficacy of ERRγ agonist DY131 in several murine models of AKI. ERRγ expression was reduced in kidneys of AKI patients and AKI murine models along with a negative correlation to the severity of AKI. Consistently, silencing ERRγ in vitro enhanced cisplatin-induced tubular cells apoptosis, while ERRγ overexpression in vivo utilizing hydrodynamic-based tail vein plasmid delivery approach alleviated cisplatin-induced AKI. ERRγ agonist DY131 could enhance the transcriptional activity of ERRγ and ameliorate AKI in various murine models. Moreover, DY131 attenuated the mitochondrial dysfunction of renal tubular cells and metabolic disorders of kidneys in AKI, and promoted the expression of the mitochondrial transcriptional factor A (TFAM). Further investigation showed that TFAM could be a target gene of ERRγ and DY131 might ameliorate AKI by enhancing ERRγ-mediated TFAM expression protecting mitochondria. These findings highlighted the protective effect of DY131 on AKI, thus providing a promising therapeutic strategy for AKI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Kidney InjuryReceptors, EstrogenAnimalsHumansMaleMiceMitochondriaMice, Inbred C57BLMetabolic DiseasesApoptosisDisease Models, AnimalTranscription FactorsCisplatinDNA-Binding Proteins

Stichwörter der Autor:innen

Acute kidney injuryERRγTFAMmetabolic disordersmitochondrial injury

Substanzen

Receptors, EstrogenESRRG protein, humanEsrrg protein, mouseTranscription FactorsCisplatinDNA-Binding Proteins

Autor:innen und Institutionen

  • Department of Nephrology, Children's Hospital of Nanjing Medical University, Nanjing, China.
  • Nanjing Key Laboratory of Pediatrics, Children's Hospital of Nanjing Medical University, Nanjing, China.
  • Jiangsu Key Laboratory of Pediatrics, Nanjing Medical University, Nanjing, China.
  • Department of Geriatrics, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang, China.

ORCID-Profile: Wei Gong, Zhanjun Jia

Förderung

  • Social Development Fund of Jiangsu Province
  • National Natural Science Foundation of China (NSFC)

Zitieren

APA

Gong, W., Lu, L., Ma, H., Shan, M., Fan, X., Bai, M., Zhang, Y., Huang, S., Jia, Z., & Zhang, A. (2024). DY131 activates ERRγ/TFAM axis to protect against metabolic disorders and acute kidney injury. Clinical Science. https://doi.org/10.1042/cs20240242

Vancouver

Gong W, Lu L, Ma H, Shan M, Fan X, Bai M, et al. DY131 activates ERRγ/TFAM axis to protect against metabolic disorders and acute kidney injury. Clinical Science. 2024. doi:10.1042/cs20240242

BibTeX
@article{Gong2024,
  author = {Gong, Wei and Lu, Lingling and Ma, Haoyang and Shan, Mingfeng and Fan, Xinwen and Bai, Mi and Zhang, Yue and Huang, Songming and Jia, Zhanjun and Zhang, Aihua},
  title = {DY131 activates ERRγ/TFAM axis to protect against metabolic disorders and acute kidney injury},
  journal = {Clinical Science},
  year = {2024},
  doi = {10.1042/cs20240242}
}
Kostenlos starten →